BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 11740718)

  • 21. Detection of circulating galactomannan in serum samples for diagnosis of Penicillium marneffei infection and cryptococcosis among patients infected with human immunodeficiency virus.
    Huang YT; Hung CC; Liao CH; Sun HY; Chang SC; Chen YC
    J Clin Microbiol; 2007 Sep; 45(9):2858-62. PubMed ID: 17596363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome.
    Mattiuzzi GN; Estey E; Raad I; Giles F; Cortes J; Shen Y; Kontoyiannis D; Koller C; Munsell M; Beran M; Kantarjian H
    Cancer; 2003 Jan; 97(2):450-6. PubMed ID: 12518369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histoplasmosis and penicilliosis: comparison of clinical features, laboratory findings and outcome.
    Mootsikapun P; Srikulbutr S
    Int J Infect Dis; 2006 Jan; 10(1):66-71. PubMed ID: 16242368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates and clinical outcomes of cryptococcal meningitis in HIV-infected patients with/without fluconazole prophylaxis.
    Manosuthi W; Sungkanuparph S; Thongyen S; Chumpathat N; Eampokalap B; Thawornwan U; Foongladda S
    J Med Assoc Thai; 2006 Jun; 89(6):795-802. PubMed ID: 16850679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML).
    Vehreschild JJ; Böhme A; Buchheidt D; Arenz D; Harnischmacher U; Heussel CP; Ullmann AJ; Mousset S; Hummel M; Frommolt P; Wassmer G; Drzisga I; Cornely OA
    J Infect; 2007 Nov; 55(5):445-9. PubMed ID: 17822770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single-dose fluconazole versus standard 2-week therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, double-blind, double-dummy trial.
    Hamza OJ; Matee MI; Brüggemann RJ; Moshi MJ; Simon EN; Mugusi F; Mikx FH; van der Lee HA; Verweij PE; van der Ven AJ
    Clin Infect Dis; 2008 Nov; 47(10):1270-6. PubMed ID: 18840077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomised, double-blind study of itraconazole versus placebo in the treatment and prevention of oral or oesophageal candidosis in patients with HIV infection.
    Smith D; Midgley J; Gazzard B
    Int J Clin Pract; 1999; 53(5):349-52. PubMed ID: 10695098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Penicilliosis.
    Powderly WG
    J Int Assoc Physicians AIDS Care; 1997 May; 3(5):25-6. PubMed ID: 11364335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A 12-case series of Penicillium marneffei pneumonia.
    Deesomchok A; Tanprawate S
    J Med Assoc Thai; 2006 Apr; 89(4):441-7. PubMed ID: 16696387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discontinuation of secondary prophylaxis for cryptococcal meningitis in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy: a prospective, multicenter, randomized study.
    Vibhagool A; Sungkanuparph S; Mootsikapun P; Chetchotisakd P; Tansuphaswaswadikul S; Bowonwatanuwong C; Ingsathit A
    Clin Infect Dis; 2003 May; 36(10):1329-31. PubMed ID: 12746781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disseminated Penicillium marneffei infection in an HIV-positive female from Thailand in Germany.
    Rimek D; Zimmermann T; Hartmann M; Prariyachatigul C; Kappe R
    Mycoses; 1999; 42 Suppl 2():25-8. PubMed ID: 10865899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. National Institute of Allergy and Infectious Diseases Mycoses Study Group.
    Saag MS; Cloud GA; Graybill JR; Sobel JD; Tuazon CU; Johnson PC; Fessel WJ; Moskovitz BL; Wiesinger B; Cosmatos D; Riser L; Thomas C; Hafner R; Dismukes WE
    Clin Infect Dis; 1999 Feb; 28(2):291-6. PubMed ID: 10064246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Itraconazole vs fluconazole as a primary prophylaxis for fungal infections in HIV-infected patients in Thailand.
    Chaiwarith R; Fakthongyoo A; Praparattanapan J; Boonmee D; Sirisanthana T; Supparatpinyo K
    Curr HIV Res; 2011 Jul; 9(5):334-8. PubMed ID: 21916838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenous and oral sequential itraconazole antifungal prophylaxis in paediatric stem cell transplantation recipients: a pilot study for evaluation of safety and efficacy.
    Grigull L; Kuehlke O; Beilken A; Sander A; Linderkamp C; Schmid H; Seidemann K; Sykora KW; Schuster FR; Welte K
    Pediatr Transplant; 2007 May; 11(3):261-6. PubMed ID: 17430480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alternate-day versus once-daily administration of amphotericin B in the treatment of cryptococcal meningitis: a randomized controlled trial.
    Techapornroong M; Suankratay C
    Scand J Infect Dis; 2007; 39(10):896-901. PubMed ID: 17852947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Voriconazole as therapy for systemic Penicillium marneffei infections in AIDS patients.
    Supparatpinyo K; Schlamm HT
    Am J Trop Med Hyg; 2007 Aug; 77(2):350-3. PubMed ID: 17690411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antifungal interventions for the primary prevention of cryptococcal disease in adults with HIV.
    Chang LW; Phipps WT; Kennedy GE; Rutherford GW
    Cochrane Database Syst Rev; 2005 Jul; (3):CD004773. PubMed ID: 16034947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Profile of central nervous system disease in HIV/AIDS patients with special reference to cryptococcal infections.
    Wadhwa A; Kaur R; Bhalla P
    Neurologist; 2008 Jul; 14(4):247-51. PubMed ID: 18617851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Penicillium marneffei infection in a Swedish HIV-infected immunodeficient narcotic addict.
    Julander I; Petrini B
    Scand J Infect Dis; 1997; 29(3):320-2. PubMed ID: 9255902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amphotericin B and itraconazole for treatment of disseminated Penicillium marneffei infection in human immunodeficiency virus-infected patients.
    Sirisanthana T; Supparatpinyo K; Perriens J; Nelson KE
    Clin Infect Dis; 1998 May; 26(5):1107-10. PubMed ID: 9597237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.